Objectives To assess the accuracy of transcutaneous bilirubin (TcB) measurements at 5 different body sites in Japanese very low birthweight (VLBW) infants and to determine a cut-off value of TcB to detect total serum/plasma bilirubin (TB) levels $10 mg/dL (171 mM).
We assessed the accuracy of TcB measurements at 5 different body sites in Japanese VLBW infants, and then determined a cut-off TcB value for detecting TB levels $10 mg/dL (171 mM), when phototherapy is initiated in VLBW infants per Japanese guidelines. 15, 16 
Methods
We performed a multicenter prospective study of 85 VLBW infants who were born from April 2013 to December 2014 and admitted to the NICU at Kobe University Hospital, Kakogawa West Municipal Hospital, Takatsuki General Hospital, Hyogo Prefectural Kobe Children's Hospital, and Japanese Red Cross Society Himeji Hospital, Japan. We received institutional review board approval from Kobe University Hospital (1450) and written informed consent from the parents.
Before enrollment of patients, the following protocol was established. In VLBW infants not receiving phototherapy or $24 hours postphototherapy, blood was collected for TB measurements based on the clinical indication by neonatologists at each hospital, and TcB measurements were then taken at some or all of 5 different body sites: forehead, sternum, upper back, lower abdomen, and/or waist. All TcB measurements were taken within 1 hour of blood sampling. Blood was collected by venipuncture, then shielded from exposure to light, and measured within 1 hour after blood sampling.
TcB was measured 3-6 times at each body site using the JM-105 jaundice meter (Konica Minolta, Inc, Tokyo, Japan) according to the manufacturer's instructions. The median value was designated as the TcB value at each measurement site. TB levels were measured by spectrophotometry using a UB-Analyzer (Arrows Co, Ltd, Osaka, Japan). 17, 18 TB values that were measured using this device correlate with those measured by high-performance liquid chromatography, which is the gold standard method for determination of TB. 4 
Validation of TcB Measurements by Examiners
To determine the consistency of TcB values, 3 independent examiners (neonatologist, resident doctor, and nurse) performed 6 replicates of TcB measurements at 5 different body sites in a VLBW infant and results were compared among users. The mean TcB values and coefficients of variation (CVs) were then calculated.
Data and Statistical Analyses
Linear regression analysis was used to determine the correlation between TcB at each body site and TB levels. 6 The regression equation and coefficient of determination (R 2 ) were calculated using the results between the TcB and TB values. In addition, R 2 were compared between 0 and 7 days of age and thereafter. Bland-Altman plots (mean AE 2 SD) were used to determine the difference between TcB at each body site and TB levels. 6 TcB cut-off values for detecting TB levels $10 mg/dL for each body site were analyzed by receiver operating characteristics (ROC) curve analyses. The sensitivity, specificity, and positive and negative predictive values (PPV and NPV) were calculated and determined for the TcB cut-off value and the best measurement site. Validation of TcB measurements by examiners was analyzed by the Kruskal-Wallis test. All analyses were conducted using Excel Statistics (Statcel 3; Social Survey Research Information Co, Ltd, Tokyo, Japan). Statistical significance was determined when P < .05.
Results
A total of 85 VLBW infants not receiving phototherapy or $24 hours postphototherapy were enrolled because TcB values did not correlate with TB levels during phototherapy (n = 35, R 2 = 0.1662). Median GA and birthweight were 29 weeks (range, 22-36 weeks) and 1154 g (range, 470-1490 g), respectively ( Table I) . Forty-two percent of infants were small for GA, which indicated that birthweight was below the 10th percentile compared with mean values at the same GA in Japanese infants. 19 All of the infants were of Japanese descent. Two infants were diagnosed with hemolysis with positive Coombs tests or elevations of carboxyhemoglobin (ABO incompatibility and unknown cause). A total of 383 blood samples from all 85 infants were analyzed (median age: 20 days; range: 1-117 days).
Precision of TcB Measurements by Examiners
The CVs for TcB measurements at each body site taken by each examiner are shown in 10%, there were no significant differences in TcB measurements taken at any body site by the 3 examiners. Figure 1 shows the linear regression analysis between TB and TcB values for the sternum and upper back. We found that TcB was significantly correlated with TB at every body site (P < .0001). R 2 was highest for the waist (0.7396, n = 157), followed by the sternum (0.6488, n = 222), upper back (0.6321, n = 177), lower abdomen (0.5430, n = 174), and then forehead (0.5294, n = 277).
Linear Regression Analysis between TB Levels and TcB Values
When we compared R 2 between 0 and 7 days of age and thereafter, R 2 was higher in infants $8 days of age than infants at 0-7 days of age at all of the body sites, except at the waist (Table III ; available at www.jpeds.com). Figure 1 shows Bland-Altman plots for the sternum and upper back. The mean value of the difference between TB and TcB values (TcB-TB) ranged from À1.1 to À1.3 at the sternum (À1.1, n = 222), lower abdomen (À1.2, n = 174), upper back (À1.3, n = 177), and forehead (À1.3, n = 277), but was À1.7 at the waist (n = 157). The 2 SDS were 3.0 at the waist, 3.7 at the sternum, 3.9 at the upper back, 4.3 at the lower abdomen, and 4.4 at the forehead.
Bland-Altman Plots of TB Levels and TcB Values
ROC Curve Analyses of TcB Values for Detecting TB Levels ‡10 mg/dL and Determination of the TcB Cut-Off Value ROC curve analyses at each body site for detecting TB levels $10 mg/dL by TcB are shown in Figure 2 . The area under the curve was more than 0.95 in at the waist, upper back, and sternum. Because the cut-off value was raised to approximately 8 in these ROC curves, we investigated the sensitivity, specificity, PPV, and NPV for a TcB cut-off value at 8. The sensitivity and NPV were both 100% at the upper back and sternum. When the TcB cut-off value was 7 at the lower abdomen and waist and 6 at the forehead, the sensitivity and NPV became 100%. However, these specificities and PPVs were lower than those at the upper back and sternum (Table IV) .
Discussion
We report TcB measurements at 5 different body sites to screen for hyperbilirubinemia in Japanese VLBW infants. Importantly, we found that the TcB cut-off value was $8 for detecting TB levels $10 mg/dL, which is the representative value for initiating phototherapy after 1 week of age in VLBW infants. 15, 16 In addition, TcB measurements taken at the sternum or upper back were more reliable than those at other body sites.
Similar to previous reports for preterm infants, 7-13 our study also showed that TcB significantly correlated with TB levels at every body site. However, R 2 at the forehead or lower abdomen was lower than that at the other sites. In agreement with previous studies, 10,14 our results clearly showed that TcB values at any body site underestimated TB levels (the difference between the 2 values was approximately 1-2 as shown by Bland-Altman analyses). Among the body sites, the waist had the greatest difference between TB and TcB values, but had the smallest SDS. More importantly, we also found that TcB $8 is needed for detecting TB levels $10 mg/dL. Because 100% sensitivity is desirable for any screening method, TcB should be measured at the sternum and upper back rather than at the forehead, lower abdomen, or waist. Although the sensitivity is 100% at the forehead, lower abdomen, and waist when the TcB cut-off value was 6 or 7, the specificity was low. Yaser et al 12 reported that the interscapular site was a better and safer screening site than the forehead or chest. Our study showed that measurements not only at the upper back, but also at the sternum were reliable. This result is different from that in term or late preterm infants who usually have TcB measured at the forehead. 6 We speculate that the TcB measurement technique is not stable and consistent at the forehead and lower abdomen because the area of the forehead in VLBW infants is too small and the lower abdomen is too soft. We also investigated if TcB measurements were different according to the examiner. We found that TcB measurements were not user-dependent, although the CV was slightly high. We consider that TcB measurement taken at the sternum and upper back can be applied to the clinical setting, with the understanding that TcB underestimates TB in VLBW infants.
TcB measurements within 7 days after birth may not be necessary because blood sampling is often performed for unstable respiratory or circulatory conditions in VLBW infants. In our study, TcB was less reliable within 7 days of birth than that thereafter, probably because of immaturity of the This study has some limitations. We do not know if the criteria of TcB for detecting TB levels $10 mg/dL and the reliable regions (sternum and upper back) can be applied to other ethnic populations. Only 2 patients who weighed less than 500 g at birth were enrolled in this study. Whether TcB measurements are accurate in these more premature infants is unknown. In spite of these limitations, we conclude that in Japanese VLBW infants the accuracy of TcB measurements varies according to body sites, and a TcB value $8 that is measured at the sternum or upper back may be reliable for detecting TB levels $10 mg/dL. n 
